Edition:
United Kingdom

Forward Pharma A/S (FWP.OQ)

FWP.OQ on NASDAQ Stock Exchange Global Select Market

2.19USD
17 May 2018
Change (% chg)

$-0.11 (-4.78%)
Prev Close
$2.30
Open
$2.28
Day's High
$2.28
Day's Low
$2.16
Volume
3,539
Avg. Vol
10,421
52-wk High
$30.00
52-wk Low
$1.64

Chart for

About

Forward Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in the development of FP187, a formulation of dimethyl fumarate (DMF) for the treatment of several inflammatory and neurological indications, including multiple sclerosis (MS). The Company's clinical candidate, FP187, is under development... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $301.51
Shares Outstanding(Mil.): 23.59
Dividend: 23.12
Yield (%): --

Financials

  FWP.OQ Industry Sector
P/E (TTM): 1.69 84.06 32.75
EPS (TTM): 3.77 -- --
ROI: 141.31 1.57 14.38
ROE: 141.32 2.43 16.07

BRIEF-Forward Pharma Says ‍European Patent Office Has Revoked EP2801355 Patent

* FORWARD PHARMA ANNOUNCES THE DECISION OF THE EUROPEAN PATENT OFFICE IN THE OPPOSITION PROCEEDINGS FOR THE EP2801355 PATENT

29 Jan 2018

BRIEF-Forward Pharma Files Further Written Submissions In European Opposition Proceeding For EP2801355 Patent

* FORWARD PHARMA FILES FURTHER WRITTEN SUBMISSIONS IN THE EUROPEAN OPPOSITION PROCEEDING FOR THE EP2801355 PATENT IN PREPARATION FOR THE ORAL HEARING IN JANUARY 2018

29 Nov 2017

BRIEF-Forward Pharma announces completion of corporate restructuring plan

* Forward Pharma announces completion of corporate restructuring plan Source text for Eikon: Further company coverage:

22 Nov 2017

Earnings vs. Estimates